s.
	The most common side effects of ULORIC include:
	liver problems
	nausea
	gout flares
	joint pain
	rash
	Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all of the possible side effects of ULORIC. For more information, ask your healthcare provider or pharmacist.
	Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
	How should I store ULORIC?
	Store ULORIC between 59°F - 86°F (15°C - 30°C).
	Keep ULORIC out of the light.
	Keep ULORIC and all medicines out of the reach of children.
	General information about the safe and effective use of ULORIC
	Medicines are sometimes prescribed for purposes other than those listed in a patient information leaflet. Do not use ULORIC for a condition for which it was not prescribed. Do not give ULORIC to other people, even if they have the same symptoms that you have. It may harm them.
	This patient information leaflet summarizes the most important information about ULORIC. If you would like more information about ULORIC talk with your healthcare provider. You can ask your healthcare provider or pharmacist for information about ULORIC that is written for health professionals. For more information go to www.uloric.com, or call 1-877-825-3327.
	What are the ingredients in ULORIC?
	Active Ingredient: febuxostat
	Inactive ingredients include: lactose monohydrate, microcrystalline cellulose, hydroxypropyl cellulose, sodium croscarmellose, silicon dioxide, magnesium stearate, and Opadry II, green
	Distributed by
	Takeda Pharmaceuticals America, Inc.
	Deerfield, IL 60015
	U.S. Patent Nos. - 6,225,474; 7,361,676; 5,614,520.
	ULORIC® is a registered trademark of Teijin Pharma Limited and used under license by Takeda Pharmaceuticals America, Inc.
	All other trademark names are the property of their respective owners
	©2009 Takeda Pharmaceuticals America, Inc.
	PI1114 R1
	February 2009
	Repackaged by Rebel Distributors Corp
	Thousand Oaks, CA 91320
	PRINCIPAL DISPLAY PANEL - 80 mg 30 Tablet Bottle
	30 Tablets
	Rx only
	Uloric®
	febuxostat
	tablets
	80 mg
	
	ULORIC
	febuxostat tablet
	Product Information
	Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 21695-516(64764-677)
	Route of Administration ORAL DEA Schedule 
	 
	Active Ingredient/Active Moiety
	Ingredient Name Basis of Strength Strength
	febuxostat(febuxostat) febuxostat 80mg
	 
	Inactive Ingredients
	Ingredient Name Strength
	lactose monohydrate 
	cellulose, microcrystalline 
	hydroxypropyl cellulose 
	croscarmellose sodium 
	silicon dioxide 
	magnesium stearate 
	 
	Product Characteristics
	Color GREEN (light green to green)  Score no score
	Shape TEAR (teardrop shaped)  Size 14mm
	Flavor  Imprint Code TAP;80 
	Contains 
	 
	Packaging
	# NDC Package Description Multilevel Packaging
	1 21695-516-30 30TABLETIn1BOTTLE None
	Marketing Information
	Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
	NDA NDA021856 02/13/2009 
	Labeler -Rebel Distributors Corp(118802834)
	Establishment
	Name Address ID/FEI